Skip to main content
. Author manuscript; available in PMC: 2018 Dec 15.
Published in final edited form as: Cancer. 2017 Sep 8;123(24):4914–4923. doi: 10.1002/cncr.30934

Figure 1.

Figure 1

Schematic portrayal of TTFR (time to first relapse/progression after diagnosis), TTP (time to progression after first enrollment on an early-phase trial), PFS time (if neuroblastoma relapse, progression, or death from neuroblastoma), and OS time (if death).